Clinical Practice and Prognostic Molecular Biomarkers in Clear Cell Renal Cell Carcinoma: Latest Advancements
Anticancer Research · 2025-10 · 45 (10) · 4131-4149
DOI: 10.21873/anticanres.17767 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anticancer Research, online erschienen am 26.09.2025. Verfasst von Gianluca Aguiari und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; dsn@unife.it. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy; dsn@unife.it.
- Department of Urology, University-Hospital of Marche, Ancona, Italy.
Zitieren
APA
Aguiari, G., & Dell'atti, L. (2025). Clinical Practice and Prognostic Molecular Biomarkers in Clear Cell Renal Cell Carcinoma: Latest Advancements. Anticancer Research, 45(10), 4131-4149. https://doi.org/10.21873/anticanres.17767
Vancouver
Aguiari G, Dell'atti L. Clinical Practice and Prognostic Molecular Biomarkers in Clear Cell Renal Cell Carcinoma: Latest Advancements. Anticancer Research. 2025;45(10):4131-4149. doi:10.21873/anticanres.17767
BibTeX
@article{Aguiari2025,
author = {Aguiari, Gianluca and Dell'atti, Lucio},
title = {Clinical Practice and Prognostic Molecular Biomarkers in Clear Cell Renal Cell Carcinoma: Latest Advancements},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {10},
pages = {4131--4149},
doi = {10.21873/anticanres.17767}
}
EUVIMED